The nifedipine gastrointestinal therapeutic system in the treatment of hypertension (original) (raw)
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS)
Dove Medical Press
2013
View PDFchevron_right
Single-Dose, Open-Label, One-Way Pharmacokinetic Studies In The Mexican Population To Evaluate The Bioavailability And Food Effect On The Pharmacokinetics Of 30-mg Extended-Release Nifedipine Tablets
Karen Nathalie Geraldo Bastida
Journal of Bioequivalence & Bioavailability, 2021
View PDFchevron_right
Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers
Fakhreddin Jamali
British Journal of Clinical Pharmacology, 1987
View PDFchevron_right
The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers
Atholl Johnston
British Journal of Clinical Pharmacology, 1986
View PDFchevron_right
Formulation of an Oral Controlled Release Dosage Form for Nifedipine
Varun Garg
2020
View PDFchevron_right
Comparative pharmacokinetics of two nifedipine products in capsule form following single oral administration in healthy volunteers
Abdelkader Battah
European Journal of Drug Metabolism and Pharmacokinetics, 1997
View PDFchevron_right
The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension
Stephen Glasser
Clinical Therapeutics, 1995
View PDFchevron_right
Pharmacokinetic Study of Nifedipine in Healthy Adult Male Human Volunteers
Ghulam Murtaza
Tropical Journal of Pharmaceutical Research, 2009
View PDFchevron_right
The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension
Stephen Glasser
Clinical Therapeutics, 1995
View PDFchevron_right
Comparison of two marketed nifedipine modified-release formulations: An exploratory clinical food interaction study
Gilberto De Nucci
Clinical Therapeutics, 2008
View PDFchevron_right
DESIGN AND EVALUATION OF GASTRORETENTIVE NIFEDIPINE FLOATING TABLETS IN THE TREATMENT OF HYPERTENSION
Editor iajps
View PDFchevron_right
Deciphering nifedipine in vivo delivery from modified release dosage forms: Identification of food effect
Ivan Kovacevic
Acta Pharmaceutica, 2015
View PDFchevron_right
Examination of two sustained release nifedipine preparations in humans and in pigs
Lloyd Sansom
European Journal of Pharmaceutical Sciences, 1996
View PDFchevron_right
Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system
Rogerio Mulinari
The American Journal of Medicine, 1987
View PDFchevron_right
Comparative in vitro dissolution of commercially available sustained release nifedipine tablet brands in the Kumasi Metropolis, Ghana
Mariam El Boakye-Gyasi, Kwabena Ofori-kwakye
Journal of Applied Pharmaceutical Science, 2015
View PDFchevron_right
Pharmacokinetics of nifedipine slow-release during sustained tocolysis
Joris van der Post
Int. Journal of Clinical Pharmacology and Therapeutics, 2015
View PDFchevron_right
Effect of food components and dosing times on the oral pharmacokinetics of nifedipine in rats
Beom-jin Lee
International Journal of Pharmaceutics, 2010
View PDFchevron_right
Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine
Ahmed Nader
The AAPS journal, 2016
View PDFchevron_right
Bioavailability and pharamcotherapeutics of nifedipine in human after single oral dose administration
Ghulam Murtaza
Acta Pharmaceutica Sciencia
View PDFchevron_right
Liquid chromatographic assay of nifedipine in human plasma and its application to pharmacokinetic studies
Tawfeeg Al-Najjar
Journal of Pharmaceutical and Biomedical Analysis, 2000
View PDFchevron_right
Combination therapy with nifedipine GITS 60 mg: subanalysis of a prospective, 12-week observational study (AdADOSE)
Wajid Hussain
Clinical and experimental hypertension (New York, N.Y. : 1993), 2015
View PDFchevron_right
G.Dinesh Babu et al: Design and Evaluation of tablets of Nifedipine
Dinesh babu
2012
View PDFchevron_right
In vitro evaluation of modified release formulations of nifedipine from Indian market
ramesh panchagnula
Indian Journal of Pharmaceutical Sciences, 2007
View PDFchevron_right
In vitro evaluation of modified release formulations of nifedipine from Indian market
rajan singh
2007
View PDFchevron_right
Investigation of the Dissolution Characteristics of Nifedipine Extended-Release Formulations Using USP Apparatus 2 and a Novel Dissolution Apparatus
Henning Blume
Dissolution Technologies, 2009
View PDFchevron_right
Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms
Sara Eyal, Michael Friedman
International Journal of Pharmaceutics, 2004
View PDFchevron_right
Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients
Kwo-chang Ueng
Clinical Drug Investigation, 2011
View PDFchevron_right
Efficacy and safety of two different formulations of nifedipine (GITS) vs slow release microgranules in patients with mild and moderate hypertension
GUSTAVO Aroca
View PDFchevron_right